In glioma development, the involvement of HUR in METTL3-mediated m6A modification of the lncRNA MALAT1 has been observed, leading to increased MALAT1 transcript expression and the promotion of glioma development through the ERK/MARK pathway [23]. The gene discussed is ELAVL1; the disease is central nervous system cancer.